Ostizeel™ is a clinically formulated joint health supplement designed to reduce pain, control inflammation, and support cartilage protection through a science-backed, multi-pathway mechanism.
Osteoarthritis is a complex, progressive condition driven by chronic inflammation, nerve sensitization, and cartilage degradation. Ostizeel™ addresses this complexity through a scientifically designed, stepwise mechanism of action that targets pain at its source while supporting long-term joint function.
The infographic below visually explains how Ostizeel™ acts at multiple levels to deliver clinically meaningful results beginning with inflammation control and extending to muscle strengthening and cartilage preservation.

Age, mechanical stress, obesity, genetics, and injury increase the risk of joint tissue breakdown, inflammation, and chronic pain.
The formulation acts on early-stage OA inflammation by regulating the release of pro-inflammatory cytokines such as TNF-α, IL-6, and IL-1β reducing tissue damage at the source.
Ostizeel™ simultaneously targets three critical components of OA pathology:
Inhibits Nociceptive Pain Pathway Activation
Modulates peripheral pain receptors triggered by joint tissue damage and inflammation.
Inhibits Neuropathic Pathway Activation
Reduces neural sensitization and neuroinflammation through interaction with mast cells, TRPV1 receptors, PPAR-α, and microglial cells.
Strengthens Peri-articular Muscle
Enhances muscle strength and function surrounding the affected joint, supporting mechanical stability and mobility.
By acting on multiple mechanisms, Ostizeel™ helps relieve pain, improve flexibility, and inhibit matrix metalloproteinases (MMPs) the enzymes responsible for cartilage degradation.
With its disease-modifying potential, Ostizeel™ supports long-term joint integrity, helping delay the progression of OA and improving overall quality of life.

